图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
真核基因表达评论综述™
影响因子: 1.841 5年影响因子: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN 打印: 1045-4403
ISSN 在线: 2162-6502

真核基因表达评论综述™

DOI: 10.1615/CritRevEukarGeneExpr.v18.i1.10
pages 1-9

Determinants of Pathologic Mineralization

Thorsten Kirsch
Musculoskeletal Research Laboratories, Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, MD 21201, USA

ABSTRACT

Physiologic mineralization is necessary for the formation of skeletal tissues and for their appropriate functions during adulthood. Mineralization has to be controlled and restricted to specific regions. If the mineralization process occurs in regions that normally do not mineralize, there can be severe consequences (pathologic or ectopic mineralization). Recent findings have indicated that physiologic and pathologic mineralization events are initiated by matrix vesicles, membrane-enclosed particles released from the plasma membranes of mineralization-competent cells. The understanding of how these vesicles are released from the plasma membrane and initiate the mineralization process may provide novel therapeutic strategies to prevent pathologic mineralization. In addition, other regulators (activators and inhibitors) of physiologic mineralization have been identified and characterized, and there is evidence that the same factors also contribute to the regulation of pathologic mineralization. Finally, programmed cell death (apoptosis) may be a contributor to physiologic mineralization and if occurring after tissue injury may induce pathologic mineralization and mineralization-related differentiation events in the injured and surrounding areas. This review describes how the understanding of mechanisms and factors regulating physiologic mineralization can be used to develop new therapeutic strategies to prevent pathologic or ectopic mineralization events.


Articles with similar content:

Cancer Treatment-Related Bone Disease
Critical Reviews™ in Eukaryotic Gene Expression, Vol.19, 2009, issue 1
Sue A. Brown, Theresa A. Guise
Recent Advances in the Use of Serological Bone Formation Markers to Monitor Callus Development and Fracture Healing
Critical Reviews™ in Eukaryotic Gene Expression, Vol.20, 2010, issue 2
Travis A. Burgers, Debra L. Sietsema, Marlon O. Coulibaly, Clifford B. Jones, Bart Williams, Jim Mason
Circulating Osteogenic Precursor Cells
Critical Reviews™ in Eukaryotic Gene Expression, Vol.20, 2010, issue 2
Robert Pignolo, Eileen M. Shore
The Cellular and Clinical Parameters of Anabolic Therapy for Osteoporosis
Critical Reviews™ in Eukaryotic Gene Expression, Vol.13, 2003, issue 1
Clifford J. Rosen
Cell Fusion in Myeloma Marrow Microenvironment: Role in Tumor Progression
Critical Reviews™ in Oncogenesis, Vol.18, 2013, issue 1 - 2
Franco Dammacco, Franco Silvestris, Mauro Cives, Sabino Ciavarella